Erratum: Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients

Article metrics

Correction to: Modern Pathology (2009) 22, 786–796; doi:10.1038/modpathol.2009.29; published online 27 March 2009

In this article, the authors have replaced Figure 3 with the following revised version:

Figure 3
figure1

Expression of transgelin in normal colorectal mucosa and primary colorectal cancer samples. There are four representative samples in each group. Immunosignals were quantified by densitometric scanning. Transgelin expression in the individual tissue samples was calculated as transgelin expression relative to GAPDH expression. Data are means±s.d. from three independent experiments. Immunoblotting analysis revealed the variation to be consistent with its appearance in the gel images (Figure 2).

Additional information

The online version of the original article can be found at 10.1038/modpathol.2009.29

Rights and permissions

Reprints and Permissions

About this article